<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05041478</url>
  </required_header>
  <id_info>
    <org_study_id>ETH11029</org_study_id>
    <nct_id>NCT05041478</nct_id>
  </id_info>
  <brief_title>Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC)</brief_title>
  <official_title>Cold Snare Endoscopic Mucosal Resection vs Cold Snare Endoscopic Mucosal Resection With Adjuvant Thermal Therapy to Resection Margins - A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western Sydney Local Health District</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western Sydney Local Health District</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomised controlled trial comparing cold snare endoscopic mucosal resection (EMR) with cold&#xD;
      snare EMR and adjuvant margin STSC in the complete resection of 15-40mm lateral-spreading&#xD;
      adenomas&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale:&#xD;
&#xD;
      Conventional EMR is well-established for the resection of lateral-spreading adenomas and has&#xD;
      been shown to be highly efficacious with adjuvant STSC. Cauterisation-related complications&#xD;
      occur relatively frequently and while endoscopically treatable, still carry morbidity not&#xD;
      seen in current cold snare polypectomy data.&#xD;
&#xD;
      Cold snare polypectomy has an excellent safety profile for smaller polyps, without&#xD;
      cauterisation-related adverse events. Limited data on cold EMR for large adenomatous&#xD;
      laterally-spreading lesions shows minimal complications. Efficacy, however, is yet to be&#xD;
      evaluated in prospective randomised trials. Observational data demonstrates recurrence rates&#xD;
      exceeding conventional EMR. Since STSC causes significant reduction in recurrence in&#xD;
      conventional EMR, the safety and efficacy of this adjuvant technique, when compared to&#xD;
      isolated cold snare EMR, has theoretical advantages in both safety and efficacy.&#xD;
&#xD;
      The safety and efficacy of these two techniques will therefore be compared in a randomised&#xD;
      controlled trial.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      Cold snare EMR of 15-40mm lateral-spreading adenomas with adjuvant STSC is expected to be&#xD;
      superior regarding complete resection and adenoma recurrence rates as compared to cold snare&#xD;
      EMR.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">June 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised Controlled Trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Blinding</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Complete resection rate (CRR)</measure>
    <time_frame>1 day</time_frame>
    <description>Determined by endoscopic assessment (no visible residual adenoma) and histological assessment (biopsies of resection margin)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adenoma recurrence rate (ARR)</measure>
    <time_frame>4-6 months</time_frame>
    <description>ARR at first surveillance colonoscopy (SC1) as determined by endoscopic assessment (no visible recurrent adenoma) and histological assessment (scar biopsies)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra-procedural and post-procedural complication rates</measure>
    <time_frame>30 days</time_frame>
    <description>Intraprocedural bleeding, clinically significant post-polypectomy bleeding, deep mural injury, post polypectomy coagulation syndrome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Colorectal Polyp</condition>
  <condition>Colon Adenoma</condition>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>Cold EMR with adjuvant STSC to margins</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard cold EMR technique with adjuvant snare tip soft coagulation to defect margins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cold EMR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Cold EMR resection technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cold Snare Endoscopic mucosal resection with adjuvant snare tip soft coagulation</intervention_name>
    <description>Use of injected chromogelofusine solution to raise a lesion prior to polypectomy. Lesion then removed with a stiff thin-wired snare. Following this defect margins are treated with electrocautery to create a rim of ablated tissue.</description>
    <arm_group_label>Cold EMR with adjuvant STSC to margins</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cold Snare Endoscopic Mucosal Resection</intervention_name>
    <description>Use of injected chromogelofusine solution to raise a lesion prior to polypectomy. Lesion then removed with a stiff thin-wired snare.</description>
    <arm_group_label>Cold EMR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any patient undergoing colonoscopy who is older than 18 years of age, has a written&#xD;
             consent for trial participation and has at least one laterally spreading lesion&#xD;
             meeting the following description:&#xD;
&#xD;
          -  Localisation in the colon or rectum&#xD;
&#xD;
          -  Benign adenomatous surface features (Kudo III / IV, Japan NBI Expert Team (JNET) 2a)&#xD;
&#xD;
          -  Granular or non-granular topography&#xD;
&#xD;
          -  Paris classification 0-IIa/IIb +/- Is&#xD;
&#xD;
          -  If present, sessile component may be no greater than 10mm in size.&#xD;
&#xD;
          -  Polyp size ranging from 15 to 40mm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current use of antiplatelet (excluding aspirin) or anticoagulants which have not&#xD;
             appropriately been interrupted according to the guidelines.&#xD;
&#xD;
          -  Known bleeding disorder or coagulopathy.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  History of inflammatory bowel disease&#xD;
&#xD;
          -  Previously attempted or otherwise non-lifting lesions&#xD;
&#xD;
          -  Endoscopic features suggestive of submucosal invasion (Kudo Vi/n, JNET 2b / 3) or&#xD;
             concurrent colorectal cancer&#xD;
&#xD;
          -  Lesions involving the ileocaecal valve (ICV), appendiceal oriface or anorectal&#xD;
             junction (ARJ)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Bourke, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Westmead Hospital (WSLHD)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathleen Goodrick</last_name>
    <phone>88905555</phone>
    <email>Kathleen.goodrick@health.nsw.gov.au</email>
  </overall_contact>
  <location>
    <facility>
      <name>Westmead Endoscopy Unit</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 2, 2021</study_first_submitted>
  <study_first_submitted_qc>September 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2021</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Western Sydney Local Health District</investigator_affiliation>
    <investigator_full_name>Professor Michael Bourke</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Polypectomy</keyword>
  <keyword>Adenoma</keyword>
  <keyword>Colorectal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

